Heparin-derived oligosaccharides interact with the phospholamban cytoplasmic domain and stimulate SERCA function

Biochemical and Biophysical Research Communications

Volumn 401, Issue 3, 2010, Pages 370-375

  Hughes, Eleri ^a   Edwards, Rachel ^a   Middleton, David A ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Heart failure; Heparin; Isothermal titration calorimetry; Oligosaccharides; Solid state NMR

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; HEPARIN; HEPARIN DERIVED OLIGOSACCHARIDE; OLIGOSACCHARIDE; PHOSPHOLAMBAN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; UNCLASSIFIED DRUG;

ACTIVE TRANSPORT; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ENZYME ACTIVITY; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; ISOTHERMAL TITRATION CALORIMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN CARBOHYDRATE INTERACTION; SARCOPLASMIC RETICULUM;

ANIMALS; CALCIUM-BINDING PROTEINS; CYTOPLASM; HEPARIN; OLIGOSACCHARIDES; PROTEIN STRUCTURE, TERTIARY; RABBITS; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 77958151603     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.09.056     Document Type: Article

References (40)

1. Fujii J., Ueno A., Kitano K., et al. Clin. Invest. 1987, 79:301-304.
2. Tada M., Inui M.J. J. Mol. Cell. Cardiol. 1983, 15:565-575.
3. Mahaney J.E., Autry J.M., Jones L.R. Kinetics studies of the cardiac Ca-ATPase expressed in Sf21 cells: new insights on Ca-ATPase regulation by phospholamban. Biophys. J. 2000, 78:1306-1323.
4. Autry J.M., Jones L.R. Functional co-expression of the canine cardiac Ca2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J. Biol. Chem. 1997, 272:15872-15880.
5. Meyer M., Schillinger W., Pieske B., et al. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 1995, 92:778-784.
6. Koss K.L., Kranias E.G. Phospholamban: a prominent regulator of myocardial contractility. Circ. Res. 1996, 79:1059-1063.
7. Schwinger R.H.G., Munch G., Bolck B., et al. Reduced Ca2+-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J. Mol. Cell. Cardiol. 1999, 31:479-491.
8. Brittsan A.G., Carr A.N., Schmidt A.G., Kranias E.G. Maximal inhibition of SERCA2 Ca2+ affinity by phospholamban in transgenic hearts overexpressing a non-phosphorylatable form of phospholamban. J. Biol. Chem. 2000, 275:12129-12135.
9. Hasenfuss G., Reinecke H., Studer R., et al. Relation between myocardial-function and expression of sarcoplasmic-reticulum Ca2+-Atpase in failing and nonfailing human myocardium. Circ. Res. 1994, 75:434-442.
10. Hobaim I.A., O'Rourke B. Decreased sarcoplasmic reticulum calcium content is responsible for defective excitation-contraction coupling in canine heart failure. Circulation 2001, 103:1577-1584.
11. Kubo H., Margulies K.B., Piacentino V., et al. Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 2001, 104:1012-1018.
12. Lindner M., Erdmann E., Beuckelmann D.J. Calcium content of the sarcoplasmic reticulum in isolated ventricular myocytes from patients with terminal heart failure. J. Mol. Cell. Cardiol. 1998, 30:743-749.
13. Schmidt A., Edes I., Kranias E.G. Phospholamban: a promising therapeutic target in heart failure?. Cardiovasc. Drugs Ther. 2001, 15:387-396.
14. BerrebiBertrand I., Lahouratate P., Lahouratate V., et al. Mechanism of action of sarcoplasmic reticulum calcium-uptake activators - discrimination between sarco(endo)plasmic reticulum Ca2+ ATPase and phospholamban interaction. Eur. J. Biochem. 1997, 247:801-809.
15. McKenna E., Smith J.S., Coll K.E., et al. Dissociation of phospholamban regulation of cardiac sarcoplasmic reticulum Ca2+ ATPase by quercetin. J. Biol. Chem. 1996, 271:24517-24525.
16. Chiesi M., Schwaller R. Reversal of phospholamban induced-inhibition of cardiac sarcoplasmic-reticulum Ca2+-ATPase by tannin. Biochem. Biophys. Res. Comm. 1994, 202:1668-1673.
17. Kimura Y., Inui M., Kadoma M., et al. Effects of monoclonal-antibody against phospholamban on calcium-pump ATPase of cardiac sarcoplasmic-reticulum. J. Mol. Cell. Cardiol. 1991, 23:1223-1230.
18. Antipenko A.Y., Spielman A.I., Sassaroli M., Kirchberger M.A. Comparison of the kinetic effects of phospholamban phosphorylation and anti-phospholamban monoclonal antibody on the calcium pump in purified cardiac sarcoplasmic reticulum membranes. Biochemistry 1997, 36:12903-12910.
19. Xu Z.C., Kirchberger M.A. Modulation by poly-electrolytes of canine cardiac microsomal calcium-uptake and the possible relationship to phospholamban. J. Biol. Chem. 1989, 264:16644-16651.
20. Kimura Y., Kurzydlowski K., Tada M., MacLennan D.H. Phospholamban regulates the Ca2+-ATPase through intramembrane interactions. J. Biol. Chem. 1996, 271:21726-21731.
21. Karim C.B., Marquardt C.G., Stamm J.D., et al. Synthetic null-cysteine phospholamban analogue and the corresponding transmembrane domain inhibit the Ca-ATPase. Biochemistry 2000, 39:10892-10897.
22. Toyofuku T., Kurzydlowski K., Tada M., Maclennan D.H. Identification of regions in the Ca2+-ATPase of sarcoplasmic reticulum that affect functional association with phospholamban. J. Biol. Chem. 1993, 268:2809-2815.
23. Toyofuku T., Kurzydlowski K., Tada M., Maclennan D.H. Amino acids Glu(2) to Ile(18) in the cytoplasmic domain of phospholamban are essential for functional association with the Ca2+-ATPase of sarcoplasmic reticulum. J. Biol. Chem. 1994, 269:3088-3094.
24. Toyofuku T., Tada M., Maclennan D.H. Amino acids Lys-Asp-Asp-Lys400 in the cardiac Ca2+-ATPase (SERCA2) are critical for functional association with phospholamban. Biophys. J. 1994, 66:A121.
25. Hughes E., Clayton J.C., Middleton D.A. Cytoplasmic residues of phospholamban interact with membrane surfaces in the presence of SERCA: a new role for phospholipids in the regulation of cardiac calcium cycling?. BBA-Biomembranes 2009, 1788:559-566.
26. Hughes G., East J.M., Lee A.G. The hydrophilic domain of phospholamban inhibits the Ca2+ transport step of the Ca2+-ATPase. Biochem. J. 1994, 303:511-516.
27. Sasaki T., Inui M., Kimura Y., et al. Molecular mechanism of regulation of Ca2+ pump ATPase by phospholamban in cardiac sarcoplasmic-reticulum - effects of synthetic phospholamban peptides on Ca2+ pump Atpase. J. Biol. Chem. 1992, 267:1674-1679.
28. Reddy L.G., Jones L.R., Cala S.E., et al. Functional reconstitution of recombinant phospholamban with rabbit skeletal Ca2+-Atpase. J. Biol. Chem. 1995, 270:9390-9397.
29. Jones L.R., Field L.J. Residues 2-25 of phospholamban are insufficient to inhibit Ca2+ transport ATPase of cardiac sarcoplasmic-reticulum. J. Biol. Chem. 1993, 268:11486-11488.
30. Lockwood N.A., Tu R.S., Zhang Z.W., et al. Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban. Biopolymers 2003, 69:283-292.
31. Cantilina T., Sagara Y., Inesi G., Jones L.R. Comparative studies of cardiac and skeletal sarcoplasmic reticulum ATPases - effect of a phospholamban antibody on enzyme activation by Ca2+. J. Biol. Chem. 1993, 268:17018-17025.
32. Hughes G., Starling A.P., Sharma R.P., East J.M., Lee A.G. An investigation of the mechanism of inhibition of the Ca2+-ATPase by phospholamban. Biochem. J. 1996, 318:973-979.
33. Waggoner J.R., Huffman J., Froehlich J.P., Mahaney J.E. Phospholamban inhibits Ca-ATPase conformational changes involving the E2 intermediate. Biochemistry 2007, 46:1999-2009.
34. Reddy L.G., Cornea R.L., Winters D.L., et al. Defining the molecular components of calcium transport regulation in a reconstituted membrane system. Biochemistry 2003, 42:4585-4592.
35. East J.M., Lee A.G. Biochemistry 1982, 21:4144-4151.
36. Hughes E., Middleton D.A. Solid-state NMR reveals structural changes in phospholamban accompanying the functional regulation of Ca2+-ATPase. J. Biol. Chem. 2003, 278:20835-20842.
37. Yoda A., Hokin L.E. On reversibility of binding of cardiotonic steroids to a partially purified (Na+, K+)-activated adenosinetriphosphatase from beef brain. Biochem. Biophys. Res. Comm. 1970, 40:880-886.
38. Douglas J.L., Trieber C.A., Afara M., Young H.S. Rapid, high-yield expression and purification of Ca2+-ATPase regulatory proteins for high-resolution structural studies. Protein Expr. Purif. 2005, 40:118-125.
39. Bennett A.E., Rienstra C.M., Auger M., et al. Heteronuclear decoupling in rotating solids. J. Chem. Phys. 1995, 103:6951-6958.
40. Andronesi O.C., Becker S., Seidel K., et al. Determination of membrane protein structure and dynamics by magic-angle-spinning solid-state NMR spectroscopy. J. Am. Chem. Soc. 2005, 127:12965-12974.